Becoming Michigan Medicine

Photo by Leisa Thompson

Dear Alumni and Friends,

Over the past year, we've made many strides to better position our academic medical center for the future. We have restructured our leadership organization to ensure optimal integration of our mission of education, research and patient care. We have new leaders in key positions and are actively recruiting to fill others. We have completed the second year of our new Medical School curriculum; we are building our research programs from discovery science to clinical trials; and we are expanding our clinical footprint across Michigan and beyond.

Along with these initiatives, we also decided to rebrand our academic medical center as Michigan Medicine. Representing the entire institution, Michigan Medicine includes our health system and its many components, and our Medical School. Michigan Medicine better reflects us as an integrated academic medical center committed to educating tomorrow's health care leaders and bringing innovation to health care. These commitments are what make Michigan Medicine unique and outstanding in providing state-of-the- art patient care.

Unique and outstanding are best demonstrated by example. In 2012, a newborn came to our pediatric hospital with a diagnosis of tracheobronchomalacia (TBM), which causes the windpipe to collapse periodically and prevent normal breathing. While severe TBM is very rare, it is often fatal. Glenn Green (M.D. 1991), a pediatric otolaryngologist, had long been frustrated by his inability to save babies with this condition, and turned to colleague Scott Hollister, Ph.D., a biomedical engineer, and his lab for help. Teaming with surgical residents and Hollister's students, the group was in the process of developing a bioresorbable device that acts as a tracheal splint. Upon hearing about the newborn, Green and Hollister saw the opportunity to put their invention into clinical practice. They obtained emergency clearance from the Food and Drug Administration to create and implant the splint, made from a biopolymer through 3-D printing.

The splint was sewn around the baby's airway to expand the trachea and give it a skeleton to aid proper growth. After three years, the splint eventually was absorbed by the body — about the same amount of time it takes the trachea to grow into a healthy state.

Since 2012, Green's team has saved the lives of two other babies with the same condition. All of them are thriving.

It is this type of collaboration, between clinicians, scientists, residents and students, that allows Michigan Medicine to do unique and often remarkable things. In the coming year, new initiatives in data sciences, precision health and biosciences will become a reality. These initiatives will build upon a concept very well illustrated by our Institute for Healthcare Policy and Innovation: that by combining the resources and strengths of the Medical School with those of other outstanding U-M schools and colleges, we can accelerate research and our ability to improve patients' lives.

These are but a few of the reasons that I am extremely excited about the future of Michigan Medicine, as I hope you are. It would be impossible to conceive what innovations our faculty, staff and students will create tomorrow to drive advances in health care research and delivery. I can't wait to see what's next.

Marschall S. Runge, M.D., Ph.D.
Dean, U-M Medical School
Executive Vice President for Medical Affairs, U-M
CEO, Michigan Medicine


More Articles About: Dean Runge Leadership Education mission Research Patient Care Medical School
Featured News & Stories Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Vision Impairment as a Risk Factor for Dementia
The population of older adults living with dementia is expected to swell to nearly 14 million by 2050 and is estimated to cost the US economy more than 500 billion each year. In the absence of a cure for Alzheimer's disease, the primary cause of dementia, there's interest in understanding modifiable risk factors. In theory, getting a handle on the modifiable risk factors for dementia, would enable public health efforts to reduce cognitive decline in dementia at the population level. We've come a long way in understanding the risk factors for Alzheimer's disease and other related dementias. However, there's still work to be done. In this episode, we'll speak with Dr. Josh Ehrlich, a researcher at the University of Michigan, who has examined vision impairment as a risk factor for dementia.
three pharmacists smiling
Health Lab
An innovative pharmacy service for pain management
An innovative service at Michigan Medicine offers pain management support for patients and care teams
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Dementia as a Global Challenge – the International Partners Study of the HRS
According to an estimate published in 2015, the global prevalence of dementia was projected to nearly triple between 2015 and 2050, growing from 46 million to over 130 million people globally. And of that worldwide share, 70% of those with dementia will be in low- and middle-income countries. Tackling and ideally preventing dementia requires a global perspective. In this episode, Matt & Donovan speak with Dr. Lindsay Kobayashi, a faculty member in the Department of Epidemiology at the University of Michigan School of Public Health whose research focuses on the social epidemiology of aging from a global perspective. Dr. Kobayashi introduces us to a whole new world of data available to help researchers tackle dementia as a global challenge.
man in scrubs sitting with scrub cap with headset on in clinical setting
Health Lab
Medical students use virtual reality to improve diabetes
A physician invents a creative approach for medical students in diabetic care.
graphic drawing of colonoscopy scan with large intestine vials patient on bed doctor
Health Lab
Investment in free follow up colonoscopies will pay off
Free colonoscopies for people whose at-home stool tests (such as Cologuard and FIT) turn up signs of potential cancer are now covered by insurance, and a study shows this will save money.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Dementia at the End of Life
Over thirty percent of individuals living with dementia living in the US each year die either of or with dementia – and almost half of those enrolled in hospice have dementia. As with so many other types of healthcare, there are disparities in both who enrolls in hospice as well as the type of care these individuals receive after enrollment. In this episode, Matt & Donovan talk with Dr. Lauren Hunt from UCSF, an expert in hospice care for persons living with dementia, about dementia at the end of life.